Phase 3 Study of Niraparib in Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

Disease Types: Prostate

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

For more information:

https://clinicaltrials.gov/ct2/show/NCT04497844?term=67652000PCR3002&draw=2&rank=1